Celldex Therapeutics, Inc. Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax
Celldex Therapeutics, Inc. (CLDX) had Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax of $85.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2026-08-06
- 2026-06-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $85.00K.
- 2026-03-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $290.00K.
- 2025-12-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $1.03M.
- 2025-09-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $1.17M.
| Period end | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2026-06-30 | $85.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $290.00K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $1.03M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $1.17M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $862.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.14M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.17M 10-K · filed 2026-02-25 |
| 2024-09-30 | $2.70M 10-Q · filed 2024-11-06 |
| 2024-06-30 | $137.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $220.00K 10-Q · filed 2024-05-06 |
| 2023-12-31 | $777.00K 10-K · filed 2025-02-27 |
| 2023-09-30 | $2.00K 10-Q · filed 2023-11-02 |
| 2023-06-30 | $2.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $59.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $5.00K 10-K · filed 2024-02-26 |
| 2022-03-31 | $2.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-09 |
| 2021-09-30 | $15.00K 10-Q · filed 2021-11-09 |
| 2020-12-31 | $5.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |